NCT05285956 is a NA clinical trial of Calm app in Pregnancy Related, sponsored by Calm.com, Inc..

Who is sponsoring NCT05285956?

NCT05285956 is sponsored by Calm.com, Inc..

What drugs are being tested in NCT05285956?

Interventions in NCT05285956: Calm app.

What condition does NCT05285956 study?

NCT05285956 studies Pregnancy Related.

Is NCT05285956 still recruiting?

NCT05285956 is currently terminated. Last updated 22 August 2022.

Last reviewed 2022-08-22 · How we verify

NCT05285956

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility of Calm to Reduce Stress and Improve Sleep During Pregnancy

Terminated NA Last updated 22 August 2022

What this trial tests

NA trial testing Calm app in Pregnancy Related in 4 participants. Terminated before completion.

Timeline

1 March 2022

Primary endpoint
1 August 2022

1 August 2022

Quick facts

Lead sponsor	Calm.com, Inc.
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	4
Start date	1 March 2022
Primary completion	1 August 2022
Estimated completion	1 August 2022
Sites	1 location across United States

Drugs / interventions tested

Calm app

Conditions studied

Pregnancy Related — all drugs for Pregnancy Related →

Sponsor

Calm.com, Inc.

Who can join

Adults 18 to 99, female only, with Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose: Test the effects of using Calm for its impact on stress, anxiety, and sleep in pregnant women using the following aims: Aim #1: Determine the feasibility of using Calm. Aim #2: Determine the preliminary efficacy of using Calm on stress, anxiety, and sleep. Exploratory Aim #3: Explore the preliminary efficacy of using Calm on self-reported birth outcomes

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pregnancy Related

Currently open trials in the same condition.

NCT05909761 — Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregn · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT07293559 — Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States · recruiting
NCT07518550 — Maternal and Fetal Electrocardiograms Separation Algorithm · NA · recruiting
NCT06965530 — Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy · NA · recruiting

Other Calm.com, Inc. trials

Trials by the same sponsor.

NCT05248711 — Project Movement/Daily Move Feasibility · NA · terminated
NCT05459168 — Development of Calm for Cancer Prototype Mobile App · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05285956 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Calm.com, Inc.
Last refreshed: 22 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05285956.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing